{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:17:22Z","timestamp":1776932242666,"version":"3.51.2"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transactions of the Royal Society of Tropical Medicine and Hygiene"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.trstmh.2007.06.013","type":"journal-article","created":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T12:55:29Z","timestamp":1185972929000},"page":"967-971","source":"Crossref","is-referenced-by-count":54,"title":["Acute viscerotropic disease following vaccination against yellow fever"],"prefix":"10.1093","volume":"101","author":[{"given":"Edward B.","family":"Hayes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.trstmh.2007.06.013_bib1","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(01)06914-8","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Adhiyaman","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.trstmh.2007.06.013_bib2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20051352","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes","volume":"202","author":"Barba-Spaeth","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trstmh.2007.06.013_bib3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(04)17017-7","article-title":"History of thymoma and yellow fever vaccination","volume":"364","author":"Barwick","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.trstmh.2007.06.013_bib4","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2337\/diabetes.38.12.1636","article-title":"Association of IDDM and attenuated response of 2\u2032,5\u2032-oligoadenylate synthetase to yellow fever vaccine","volume":"38","author":"Bonnevie-Nielsen","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.trstmh.2007.06.013_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CDLI.2.3.302-306.1995","article-title":"Lymphocytic 2\u2032,5\u2032-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine","volume":"2","author":"Bonnevie-Nielsen","year":"1995","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.trstmh.2007.06.013_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.trstmh.2007.06.013_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2006.02.005","article-title":"Yellow fever vaccine-associated viscerotropic disease and death in Spain","volume":"36","author":"Doblas","year":"2006","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.trstmh.2007.06.013_bib8","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2006.01.009","article-title":"Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil","volume":"24","author":"Engel","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.trstmh.2007.06.013_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/viro.2001.1168","article-title":"Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil","volume":"290","author":"Galler","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.trstmh.2007.06.013_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.SMJ.0000157537.11806.DC","article-title":"Rare case of fatal yellow fever vaccine-associated viscerotropic disease","volume":"98","author":"Gerasimon","year":"2005","journal-title":"South Med. J."},{"key":"10.1016\/j.trstmh.2007.06.013_bib11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0091-6749(99)70245-9","article-title":"Anaphylaxis from yellow fever vaccine","volume":"103","author":"Kelso","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.trstmh.2007.06.013_bib12","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","author":"Kengsakul","year":"2002","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.trstmh.2007.06.013_bib13","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.trstmh.2007.06.013_bib14","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.vaccine.2004.01.026","article-title":"Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX","volume":"22","author":"Kitchener","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.trstmh.2007.06.013_bib15","first-page":"307","article-title":"Surveillance of adverse events following immunisation: Australia, 2000\u20132002","volume":"27","author":"Lawrence","year":"2003","journal-title":"Commun. Dis. Intell."},{"key":"10.1016\/j.trstmh.2007.06.013_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.trstmh.2007.06.013_bib17","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2006.11.027","article-title":"Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases","volume":"25","author":"McMahon","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.trstmh.2007.06.013_bib18","series-title":"Vaccines","first-page":"1095","article-title":"Yellow fever vaccine","author":"Monath","year":"2004"},{"key":"10.1016\/j.trstmh.2007.06.013_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1099\/vir.0.82272-0","article-title":"Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells","volume":"88","author":"Palmer","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.trstmh.2007.06.013_bib20","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1073\/pnas.142287799","article-title":"Positional cloning of the murine flavivirus resistance gene","volume":"99","author":"Perelygin","year":"2002","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.trstmh.2007.06.013_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.qco.0000178823.28585.ad","article-title":"New developments in flavivirus vaccines with special attention to yellow fever","volume":"18","author":"Pugachev","year":"2005","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.trstmh.2007.06.013_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-0-387-34814-8_3","article-title":"Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D","volume":"590","author":"Querec","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.trstmh.2007.06.013_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8 and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J. Exp. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.trstmh.2007.06.013_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1590\/S0037-86822004000700011","article-title":"Yellow fever virus isolated from a fatal post vaccination event: an experimental comparative study with the 17DD vaccine strain in the Syrian hamster (Mesocricetus auratus)","volume":"37","author":"Rodrigues","year":"2004","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.trstmh.2007.06.013_bib25","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1128\/JVI.80.6.2987-2999.2006","article-title":"RNase L plays a role in the antiviral response to West Nile virus","volume":"80","author":"Scherbik","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.trstmh.2007.06.013_bib26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1017\/S0950268804002602","article-title":"Risk of fatal adverse events associated with 17DD yellow fever vaccine","volume":"132","author":"Struchiner","year":"2004","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.trstmh.2007.06.013_bib27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/00002030-200403260-00020","article-title":"Yellow fever vaccine is safe and effective in HIV-infected patients","volume":"18","author":"Tattevin","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.trstmh.2007.06.013_bib28","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/S0140-6736(01)06916-1","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Troillet","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.trstmh.2007.06.013_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.trstmh.2007.06.013_bib30","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3201\/eid1009.040197","article-title":"Genetic divergence and dispersal of yellow fever virus, Brazil","volume":"10","author":"Vasconcelos","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.trstmh.2007.06.013_bib31","first-page":"936","article-title":"Adverse effects of attenuated yellow fever vaccine with multiple organ injury\u2014a case report","volume":"85","author":"Zhou","year":"2005","journal-title":"Zhonghua Yi Xue Za Zhi."}],"container-title":["Transactions of the Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/trstmh\/article-pdf\/101\/10\/967\/5355545\/101-10-967.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T14:23:08Z","timestamp":1587824588000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article-lookup\/doi\/10.1016\/j.trstmh.2007.06.013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0035920307002039"],"URL":"https:\/\/doi.org\/10.1016\/j.trstmh.2007.06.013","relation":{},"ISSN":["0035-9203"],"issn-type":[{"value":"0035-9203","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}